|1.||Tikhonova, E G: 2 articles (01/2000 - 01/2000)|
|2.||Archakov, A I: 2 articles (01/2000 - 01/2000)|
|3.||Kovalev, O B: 2 articles (01/2000 - 01/2000)|
|4.||Kniazhev, V A: 2 articles (01/2000 - 01/2000)|
|5.||Ipatova, O M: 2 articles (01/2000 - 01/2000)|
|6.||Torkhovskaia, T I: 2 articles (01/2000 - 01/2000)|
|7.||Uchaĭkin, V F: 2 articles (01/2000 - 01/2000)|
|8.||Zhao, Jing: 1 article (01/2014)|
|9.||Yu, Yi-Qun: 1 article (01/2014)|
|10.||Liu, Min: 1 article (01/2014)|
|1.||Liver Diseases (Liver Disease)
01/01/2000 - "Besides, the above results broaden usage field of polyunsaturated phosphatidylcholine as cell membranes repair agent: it appears to be effective not only for liver diseases treatment, but also for soonest overcome of post-surgery liver changes."
09/01/1978 - "Membrane lipid composition of red blood cells in liver disease: regression of spur cell anaemia after infusion of polyunsaturated phosphatidylcholine."
06/01/2013 - "Soybean polyunsaturated phosphatidylcholine (PC) is thought to exert anti-inflammatory activities and has potent effects in attenuating acute renal failure and liver dysfunction. "
07/31/1982 - "[Use of polyunsaturated phosphatidylcholine (EPL) in combination with vitamin B complex in therapy of liver diseases]."
03/31/1987 - "[Effect of polyunsaturated phosphatidylcholine and vitamin B complex on the metabolism of selenium homotaurocholic acid in patients with chronic liver disease]."
|2.||Crohn Disease (Crohn's Disease)
10/01/1996 - "There was also a fall to normal values in 16:0-20:4 (to 7.7 +/- 0.6%, P < 0.01 compared with the pretreatment value) and in 16:0-22:6 (to 5.7 +/- 0.5%, P not significant), by week 8. 5. The proportions of polyunsaturated phosphatidylcholine molecular species were increased in the plasma of patients with active Crohn's disease, but fell to normal levels during disease remission. "
|4.||Chronic Hepatitis (Chronic Active Hepatitis)
08/01/1983 - "Studies were carried out to investigate the mechanisms underlying the reduction of hepatocellular necrosis observed when polyunsaturated phosphatidylcholine was administered to patients with HBsAg negative chronic active hepatitis. "
01/15/1988 - "[Polyunsaturated phosphatidylcholine combined with vitamin B complex in the treatment of chronic active hepatitis with cirrhosis]."
12/01/2009 - "Fatty liver model of rats were established simply by 10 weeks of high-fat diet feeding, and starting from the 7th week of modeling, they were gastric perfused respectively with saline (model group), high-dose QHD (QHDh group), low-dose QHD (QHDI group) and polyene phosphatidylcholine (PP group) for successive 4 weeks. "
06/13/1994 - "[The effect of polyene phosphatidylcholine (Essentiale forte) in the treatment of liver steatosis and ultrasound findings--preliminary study]."
|1.||Hepatitis B Surface Antigens (HBsAg)
|2.||essential 303 forte
|3.||Vitamin B Complex (B Vitamins)
|7.||Glycyrrhizic Acid (Glycyrrhizin)
|8.||Ursodeoxycholic Acid (Urso)